Oscar Health (NYSE:OSCR) Trading Up 6.6% - Still a Buy?

Key Points

• The stock price of Oscar Health (NYSE:OSCR) increased by 6.6% to $15.65, although trading volume dropped by 56% compared to its average.
• Analysts have downgraded Oscar Health's ratings, with six rating it as a sell and predicting an average price target of $12.07.
• Despite a 29% year-over-year revenue increase, Oscar Health reported a quarterly loss of ($0.89) EPS, slightly above analyst expectations.

Shares of Oscar Health, Inc. (NYSE:OSCR - Get Free Report) traded up 6.6% on Friday . The company traded as high as $15.89 and last traded at $15.65. 5,846,092 shares changed hands during trading, a decline of 56% from the average session volume of 13,198,716 shares. The stock had previously closed at $14.68.

Wall Street Analysts Forecast Growth

Several equities analysts have commented on OSCR shares. Piper Sandler reissued a "neutral" rating and set a $13.00 price objective (down previously from $14.00) on shares of Oscar Health in a research report on Thursday. Barclays cut their price objective on shares of Oscar Health from $17.00 to $11.00 and set an "underweight" rating on the stock in a research report on Wednesday, July 23rd. Raymond James Financial cut Oscar Health from an "outperform" rating to a "market perform" rating in a report on Tuesday, June 24th. Robert W. Baird restated a "neutral" rating and set a $14.00 target price (down from $28.00) on shares of Oscar Health in a research note on Friday, July 25th. Finally, Baird R W cut shares of Oscar Health from a "strong-buy" rating to a "hold" rating in a report on Friday, July 25th. Six equities research analysts have rated the stock with a sell rating and four have issued a hold rating to the company's stock. Based on data from MarketBeat.com, the company currently has a consensus rating of "Reduce" and a consensus target price of $12.07.

Oscar Health Price Performance

The company has a 50-day moving average price of $15.98 and a 200-day moving average price of $14.79. The company has a debt-to-equity ratio of 0.26, a quick ratio of 0.86 and a current ratio of 0.86. The company has a market capitalization of $4.39 billion, a price-to-earnings ratio of -20.90 and a beta of 1.86.

Oscar Health (NYSE:OSCR - Get Free Report) last released its quarterly earnings data on Wednesday, August 6th. The company reported ($0.89) earnings per share for the quarter, beating analysts' consensus estimates of ($0.90) by $0.01. Oscar Health had a negative net margin of 1.50% and a negative return on equity of 13.78%. The business had revenue of $2.86 billion during the quarter, compared to analyst estimates of $2.88 billion. During the same period in the previous year, the business earned $0.20 EPS. Oscar Health's revenue was up 29.0% compared to the same quarter last year. On average, equities research analysts expect that Oscar Health, Inc. will post 0.69 EPS for the current fiscal year.

Institutional Trading of Oscar Health

A number of institutional investors and hedge funds have recently made changes to their positions in OSCR. Raymond James Financial Inc. acquired a new position in Oscar Health during the fourth quarter worth approximately $6,613,000. Summit Investment Advisors Inc. boosted its holdings in Oscar Health by 5.8% in the 4th quarter. Summit Investment Advisors Inc. now owns 20,838 shares of the company's stock worth $280,000 after buying an additional 1,141 shares during the period. Barclays PLC grew its holdings in shares of Oscar Health by 10.8% during the fourth quarter. Barclays PLC now owns 361,062 shares of the company's stock worth $4,852,000 after purchasing an additional 35,244 shares in the last quarter. NewEdge Advisors LLC lifted its position in Oscar Health by 9,811.2% in the fourth quarter. NewEdge Advisors LLC now owns 99,112 shares of the company's stock valued at $1,332,000 after purchasing an additional 98,112 shares during the last quarter. Finally, Canada Pension Plan Investment Board grew its stake in shares of Oscar Health by 510.3% in the 4th quarter. Canada Pension Plan Investment Board now owns 958,200 shares of the company's stock worth $12,878,000 after buying an additional 801,200 shares during the last quarter. 75.70% of the stock is currently owned by institutional investors and hedge funds.

Oscar Health Company Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.